31 January 2023 : Navitas Data Sciences, the global Functional Service Provider (FSP) division of Navitas Life Sciences,
Navitas Life Sciences today announced that it has been named as a Major Player in the...
Navitas Life Sciences today announced that it has been named as a Top 10 Innovator – Pharma and Life Sciences Solution Providers 2022 by Medhealth Outlook.
H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to
Navitas Life Sciences, a provider of Clinical, Pharmacovigilance, and Regulatory solutions, today announced that it has been named a ‘Major Contender’ in the Everest Group’s Clinical Development Platforms Products PEAK Matrix® Assessment 2022.
Navitas Life Sciences, a provider of Pharmacovigilance, Regulatory, and Clinical solutions, today announced that it has been named as a ‘Major Contender’ in the Everest Group’s Life Sciences Operations PEAK Matrix® Assessment 2022.
10 January, 2022 Navitas Data Sciences, the global Functional Service Provider (FSP) division of Navitas Life Sciences, are delighted that Shrishaila Patil our Vice President of Statistical Programming,
Navitas Life Sciences, a technology-backed global Clinical Research Organization (CRO) and UL, the global safety science leader,
Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and provider of Pharmacovigilance, Regulatory, and Clinical solutions
Navitas Life Sciences, a TAKE Solutions company, announces that it has achieved its 200th customer win for its innovative Regulatory Technology,